Navigation Links
The Renal Anemia Market Shows Signs of Stabilization but Changes are Occurring in the Bone and Mineral Metabolism Market
Date:10/27/2010

EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc. released two syndicated Nephrology TreatmentTrends® publications (TreatmentTrends®: US Nephrology Q310 and TreatmentTrends®: Renal Dietitians 2010). These reports provide information gleaned from on-line surveys with 200 nephrologists and 205 renal dietitians and capture insight into attitudes, perceptions and self-reported prescribing behavior with a focus on renal anemia and bone and mineral metabolism in chronic kidney disease and dialysis.  

In the renal anemia market, use of erythropoietin stimulating agents (ESAs) in patients with chronic kidney disease, not on dialysis (CKD-ND) is showing signs of stabilization. Although use is still far lower than it was just a few years ago, for the first time in almost a year, the percent of Stage 4 CKD-ND patients on ESAs is trending up instead of down. While not a statistically significant change, use of Centocor Ortho-Biotech's Procrit is lower than in prior quarters, and monthly contact rates for Procrit representatives are significantly lower than last year and than monthly contact rates for Amgen's Aranesp. Procrit also seems to be losing a competitive advantage on a number of attributes it once "owned". Despite prior projections of increased use of intravenous (IV) iron, use has remained steady as have the percent of nephrologists who report stocking and administering IV iron in their office. Use of the newest IV iron agent, AMAG's Feraheme, is showing signs of a plateau; for the third quarter in a row, Feraheme share has remained relatively flat among IV iron treated CKD-ND patients. Moreover, the percent of nephrologists reporting use of Feraheme has not changed.

There have been some major changes in the bone and mineral metabolism market, particularly as it relates to parathyroid hormone (PTH) modifiers. The majority of both nephrologists and renal dietitians are aware that DaVita, one of
'/>"/>

SOURCE BioTrends Research Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
4. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
5. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
6. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
7. Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium
8. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
9. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
10. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
11. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 ... announced the addition of the "Surgical/Operating Microscopes ... Forecast to 2020" report to their offering. ... global surgical microscopes market is poised to reach ... 2014, at a CAGR of 12.3% from 2015 ...
(Date:5/29/2015)... 29, 2015  Haemonetics Corporation (NYSE: HAE ) ... Officer, will present at the JMP Securities Life Sciences ... June 23 rd , 2015 at 11:30am Eastern time.  ... presentation live via webcast at: http://wsw.com/webcast/jmp27/hae ... ) is a global healthcare company dedicated to providing ...
(Date:5/29/2015)... , May 29, 2015  Epic Sciences announced ... sequencing data, from metastatic castrate resistant prostate cancer ... American Society for Clinical Oncology. This application expands ... cell left behind™ platform to characterize circulating ... that late stage patients have heterogeneous clonal CTC ...
Breaking Medicine Technology:Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3
... 9, 2011 As the Occupy Oakland General Strike ... Peter Allen was waiting for a jury to tell ... and greed in business dealings.  Mr. Allen had been ... three years.  Closing arguments were given on Wednesday, November ...
... PITTSBURGH, Nov. 9, 2011 Mylan Inc. (Nasdaq: ... to action in the global fight against HIV/AIDS. ... industry has made significant contributions toward making HIV/AIDS medicines ... to expanding access to treatment for more people. As ...
Cached Medicine Technology:Occupy Oakland Business Fraud Verdict: Oakland Jury Awards $9 Million Against Multi-National Corporation for Business Fraud and Breach of Contract 2Mylan Applauds Obama Administration's Call to Create an "AIDS-Free Generation" Through Global Fight Against HIV/AIDS 2
(Date:5/29/2015)... The annual aesthetic meeting, put on by the American ... from May 14-19th. This global event sets a gold ... world; dedicating itself exclusively to cosmetic medicine. Dr. Paul ... to attend this year’s meeting. , Among the classes ... given the honor of sitting at the presenter’s table during ...
(Date:5/29/2015)... 29, 2015 Vulvodynia is defined as ... significant physical, sexual, and psychological distress. Women’s ... Vulvodynia. The actual diagnosis is often made on the ... realize that this problem can be very troublesome to ... these symptoms, they need to schedule and appointment with ...
(Date:5/29/2015)... Health DataPalooza is a national conference that brings ... the most effective and innovative ways to use open ... by the Health Data Consortium, which is a collaboration ... develop the use of open healthcare data. Within ... in on how to actually put the ideas into ...
(Date:5/29/2015)... News: 2015-2016 Oil Market Forecast, Company: Carson ... , In July, 2014, the price of ... in US shale production and increased production from Saudi ... share from US shale producers, started producing close to ... out into the marketplace, they could push oil prices ...
(Date:5/29/2015)... Texas (PRWEB) May 29, 2015 Testosterone Centers ... the DFW area, is opening a new center in the ... the rest of the Mid Cities. Located on the south ... Road in Hurst, the new testosterone center will open in ... women who suffer from low testosterone. , Like TCT’s other ...
Breaking Medicine News(10 mins):Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 2Health News:RowdMap, Inc. Speaks on Government Health Data and Applications for Transparency, No Value Care, and Pay-for-Value Risk Arrangements at Health Datapalooza 3Health News:Breaking News: Carson Energy Releases 2015-2016 Oil Forecast 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 2Health News:Testosterone Clinics in Colleyville — TCT opens Hurst Location 3
... , , , ... TUSTIN, Calif. , July 14 Peregrine Pharmaceuticals, Inc. (Nasdaq: ... (FY) 2009 ended April 30, 2009. Total revenues for the fourth quarter ... in FY 2008. Total revenues for the 2009 fiscal year increased approximately ...
... , NEW YORK, July 14 Delcath Systems, Inc. (Nasdaq: ... for the second quarter ended June 30, 2009 on Monday, July 27, ... Eamonn Hobbs, the Company,s new President & CEO ... 2009 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss ...
... , DEERFIELD BEACH, Fla., July 14 A ... suggests drinking fat-free milk in the morning may be better than drinking ... However, the study only looks at feeling full, not weight loss ... are intolerant to proteins in milk, or lactose intolerant, which can cause ...
... ... under the knife? Advances in fractional laser technology have resulted in the Fractional Eyelift, a ... Bruce Katz of the Juva Skin & Laser Center pioneered the procedure. , ... (PRWEB) July 14, 2009 -- For many, ...
... , ... Institute and EmpowHer Publish a Series of Women,s Cardiovascular Health Content , ... Scottsdale, Arizona (PRWEB) July 14, ... and EmpowHer, ( www.empowher.com ), the home for women,s health online, today announced a ...
... , ... prescription discount card, Niche Prescriptions announces the grand opening of a new program. The ... one of the largest pharmacy networks in the United States and offers thousands of ... ...
Cached Medicine News:Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 2Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 3Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 4Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 5Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 6Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 7Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 8Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 9Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 10Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 11Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 12Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 13Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 14Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 15Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 16Health News:Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009 17Health News:Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress 2Health News:Milk: Does It Do A Body Good? 2Health News:Milk: Does It Do A Body Good? 3Health News:Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 2Health News:Fractional Eyelift Procedure Reduces Eyelid Drooping and Wrinkles with Minimal Recovery Time 3Health News:Free Women's Heart Health Information Now Available 2Health News:Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 2Health News:Niche Prescriptions Announces Grand Opening of New Program Offering Prescription Drug Discount Card 3
SunGlide™ Stylette - Green Adult. Use in 7.0 to 10mm tubes. 25/box....
SunGlide™ Stylette - Blue Neonatal. Use in 2.0 to 3.5mm tubes. 25/box....
Disposable Aluminum Satin Finish E/T Stylette, Adult 16, 25/box....
Solid Copper Malleable with Adjustable Stop 14.75....
Medicine Products: